Regeneron Pharmaceuticals
REGN
REGN
1,155 hedge funds and large institutions have $66.7B invested in Regeneron Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 169 funds opening new positions, 336 increasing their positions, 462 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
12% less funds holding in top 10
Funds holding in top 10: 34 → 30 (-4)
19% less call options, than puts
Call options by funds: $1.27B | Put options by funds: $1.57B
27% less repeat investments, than reductions
Existing positions increased: 336 | Existing positions reduced: 462
Holders
1,155
Holding in Top 10
30
Calls
$1.27B
Puts
$1.57B
Top Buyers
| 1 | +$291M | |
| 2 | +$252M | |
| 3 | +$207M | |
| 4 |
Goldman Sachs
New York
|
+$94.4M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$71.4M |
Top Sellers
| 1 | -$273M | |
| 2 | -$233M | |
| 3 | -$231M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$185M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$183M |